In Brief: American BioMed
This article was originally published in The Gray Sheet
Executive Summary
American BioMed: Firm's Ahn dual balloon thrombectomy catheter will be rolled out in the second quarter following receipt of 510(k) clearance on Jan. 20. The firm's tenth FDA-cleared balloon catheter employs a distal dual balloon design, which the firm claims more effectively traps blood clots and prevents blood contamination. The Ahn also incorporates a proximal indicator safety balloon intended to permit visual determination of inflation volume...